세계의 이명용 디지털 치료제 시장 보고서(2025년)
Digital Therapeutics For Tinnitus Global Market Report 2025
상품코드 : 1877614
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

이명용 디지털 치료제 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 14억 달러에서 2025년에는 17억 8,000만 달러에 달할 것으로 추정되며, CAGR 27.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 이명의 유병률 증가, 디지털 건강 솔루션의 도입 확대, 이명 관리에 대한 인식 향상, 의료 분야의 디지털화 진전 및 개인화 치료 옵션에 대한 수요 증가로 인한 것입니다.

이명용 디지털 치료제 시장 규모는 향후 수년간 급격한 성장이 예상됩니다. 2029년에는 46억 4,000만 달러에 달할 것으로 예측되며, CAGR 27.1%로 성장할 전망입니다. 예측 기간 동안의 성장은 고령화 인구 증가, 소음성 난청증 사례 증가, 의료비 지출 확대, 만성질환 유병률 상승, 재택치료 솔루션 수요 증가로 인한 것으로 보입니다. 예측 기간 주요 동향에는 기술 진보, 디지털 치료제 혁신, 신경조절 요법 개발, 연구 개발 투자 증가, 치료에 대한 인공지능 통합이 포함됩니다.

디지털 헬스 솔루션의 보급 확대는 향후 수년간 이명용 디지털 치료제 시장의 성장을 견인할 것으로 예측됩니다. 디지털 건강은 의료 제공 강화, 환자 결과 개선, 헬스케어 지원을 목적으로 한 디지털 기술, 연결 도구 및 데이터 구동 플랫폼의 활용을 의미합니다. 스마트폰과 인터넷에 대한 액세스가 확대됨에 따라 환자가 언제 어디서나 의료 서비스에 연결할 수 있는 환경이 갖추어져 도입이 진행되고 있습니다. 이명용 디지털 치료제는 모바일 건강 앱, 원격 의료 플랫폼, 증거 기반 개입 수단을 제공함으로써 이러한 연결성을 활용하고 접근하기 쉽고 편리한 솔루션을 제공합니다. 예를 들어 2023년 12월 영국 국민보건서비스(NHS)가 발표한 데이터에 따르면 디지털 헬스 앱 이용자 수는 2022년 1,680만 명에서 3,360만 명으로 증가하였고, 월간 로그인수는 1,680만 명에서 2,580만 명으로 54% 증가했습니다. 이는 디지털 건강 솔루션의 보급 확대가 이명용 디지털 치료제 시장을 견인하고 있음을 보여줍니다.

이명용 디지털 치료제 시장의 주요 기업은 청각 처리 능력과 정신 건강 성과 향상을 목적으로 한 신경 행동 장애용 디지털 치료제 등의 혁신에 주력하고 있습니다. 신경 행동 장애용 디지털 치료제란, 인지 기능, 정서 기능 및 감각 기능을 개선하는 개별화된 디지털 프로그램을 제공하는 것으로, 이명, 우울증 및 불안 장애 등의 신경학적 및 행동적 상태를 예방, 관리, 치료하는 소프트웨어 구동형의 근거에 기반한 개입법입니다. 2025년 2월, 한국에 본사를 둔 Neurive사는 이명과 우울증을 위한 디지털 치료제 'SoriCLEAR'를 발표했습니다. 신경조절, 치매, 우울증을 전문으로 하는 고려대학 교수이며, 회사 CEO인 송재중 씨의 지도하에 개발된 SoriCLEAR는 인공지능을 이용하여 연령, 성별, 이명의 빈도와 중증도 등의 요인을 평가하고, 개별 환자를 위한 맞춤 치료 계획을 가능하게 합니다. 솔리클리아는 한국 식품의약품안전처에서 국내 5번째 이명 치료용 디지털 치료제로 승인되어 임상 사용이 가능해졌습니다. 비침습적인 치료 옵션으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Digital therapeutics for tinnitus are evidence-based digital interventions designed to manage or alleviate the perception of tinnitus through software-driven therapies. These solutions use technologies such as mobile applications, artificial intelligence, and data analytics to deliver personalized sound therapy and behavioral support. They aim to enhance auditory health and overall well-being through continuous digital engagement and clinically validated therapeutic methods.

The primary product types of digital therapeutics for tinnitus include software applications, devices, and services. Software applications are clinically validated programs that provide therapeutic interventions to manage tinnitus symptoms and improve auditory health. These solutions employ therapies such as cognitive behavioral therapy, sound therapy, educational therapy, and others, and are distributed via online platforms, hospitals and clinics, and other channels. Key end users include adults, pediatric patients, and geriatrics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for tinnitus market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for tinnitus market statistics, including the digital therapeutics for tinnitus industry global market size, regional shares, competitors with the digital therapeutics for tinnitus market share, detailed digital therapeutics for tinnitus market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics for tinnitus industry. This digital therapeutics for tinnitus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics for tinnitus market size has grown exponentially in recent years. It will grow from $1.40 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 27.4%. The growth during the historic period is attributed to the increasing prevalence of tinnitus, rising adoption of digital health solutions, growing awareness of tinnitus management, expanding healthcare digitization, and increasing demand for personalized treatment options.

The digital therapeutics for tinnitus market size is expected to see exponential growth in the next few years. It will grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth during the forecast period is attributed to a growing aging population, increasing cases of noise-induced hearing loss, rising healthcare expenditure, higher prevalence of chronic conditions, and growing demand for home-based healthcare solutions. Key trends in the forecast period include technological advancements, innovations in digital therapeutics, developments in neuromodulation therapies, increased investment in research and development, and integration of artificial intelligence in treatment.

The rising adoption of digital health solutions is expected to drive the growth of the digital therapeutics for tinnitus market in the coming years. Digital health encompasses the use of digital technologies, connected tools, and data-driven platforms to enhance healthcare delivery, improve patient outcomes, and support health management. Adoption is increasing as more people gain access to smartphones and the internet, enabling patients to connect with healthcare services anytime and anywhere. Digital therapeutics for tinnitus leverage this connectivity by providing mobile health apps, telemedicine platforms, and evidence-based interventions that are both accessible and convenient. For example, in December 2023, the UK National Health Service reported that digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins increasing 54% from 16.8 million to 25.8 million. This demonstrates that the growing adoption of digital health solutions is driving the digital therapeutics for tinnitus market.

Leading companies in the digital therapeutics for tinnitus market are focusing on innovations such as digital therapeutics for neuro-behavioral disorders to enhance auditory processing and mental health outcomes. Digital therapeutics for neuro-behavioral disorders are software-driven, evidence-based interventions designed to prevent, manage, or treat neurological and behavioral conditions, including tinnitus, depression, or anxiety, by delivering personalized digital programs that improve cognitive, emotional, or sensory functions. In February 2025, South Korea-based Neurive introduced SoriCLEAR, a digital therapeutic for tinnitus and depression. Developed under the leadership of CEO Jae-Jun Song, a Korea University professor specializing in neuromodulation, dementia, and depression, SoriCLEAR uses artificial intelligence to assess factors such as age, gender, tinnitus frequency, and severity, enabling personalized treatment plans for individual patients. SoriCLEAR has been approved by Korea's Ministry of Food and Drug Safety as the country's fifth digital therapeutic for tinnitus and is available for clinical use, offering a promising non-invasive treatment option.

In August 2024, Ireland-based Neuromod Devices partnered with the University of South Dakota Speech, Language, and Hearing Clinic to expand access to its Lenire bimodal neuromodulation device for tinnitus treatment. The University of South Dakota clinic provides assessment and therapy services for speech, language, and hearing disorders, and this partnership aims to broaden access to Neuromod Devices' FDA-approved tinnitus treatment solution.

Major players in the digital therapeutics for tinnitus market are Sonova Holding AG, Starkey Hearing Technologies, Oticon A/S, ASKA Pharmaceutical Co. Ltd., Beltone, InfectoPharm Arzneimittel und Consilium GmbH, Signia, Oto Health Inc., Neuromod Devices Ltd., Mahana Therapeutics Inc., AudioCardio Inc., Neuromonics Inc., Treble Health Ltd., Sound Oasis LLC, AppyHapps Inc., Auricle Inc., TrueSilence Inc., MindEar Ltd., Tinnitracks, Tonal Tinnitus Therapy.

North America was the largest region in the digital therapeutics for tinnitus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for the tinnitus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics for the tinnitus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for the tinnitus market consist of revenues earned by entities by providing services such as remote therapy monitoring, teleconsultation support, data analytics and reporting services, patient engagement and coaching programmes and subscription-based therapy management. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for the tinnitus market include sales of wearable sound generators, smart headbands and earbuds, AI-powered therapy platforms, neurostimulation devices and virtual reality (VR) therapy systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics For Tinnitus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics for tinnitus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for digital therapeutics for tinnitus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for tinnitus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Digital Therapeutics For Tinnitus Market Characteristics

3. Digital Therapeutics For Tinnitus Market Trends And Strategies

4. Digital Therapeutics For Tinnitus Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Digital Therapeutics For Tinnitus Growth Analysis And Strategic Analysis Framework

6. Digital Therapeutics For Tinnitus Market Segmentation

7. Digital Therapeutics For Tinnitus Market Regional And Country Analysis

8. Asia-Pacific Digital Therapeutics For Tinnitus Market

9. China Digital Therapeutics For Tinnitus Market

10. India Digital Therapeutics For Tinnitus Market

11. Japan Digital Therapeutics For Tinnitus Market

12. Australia Digital Therapeutics For Tinnitus Market

13. Indonesia Digital Therapeutics For Tinnitus Market

14. South Korea Digital Therapeutics For Tinnitus Market

15. Western Europe Digital Therapeutics For Tinnitus Market

16. UK Digital Therapeutics For Tinnitus Market

17. Germany Digital Therapeutics For Tinnitus Market

18. France Digital Therapeutics For Tinnitus Market

19. Italy Digital Therapeutics For Tinnitus Market

20. Spain Digital Therapeutics For Tinnitus Market

21. Eastern Europe Digital Therapeutics For Tinnitus Market

22. Russia Digital Therapeutics For Tinnitus Market

23. North America Digital Therapeutics For Tinnitus Market

24. USA Digital Therapeutics For Tinnitus Market

25. Canada Digital Therapeutics For Tinnitus Market

26. South America Digital Therapeutics For Tinnitus Market

27. Brazil Digital Therapeutics For Tinnitus Market

28. Middle East Digital Therapeutics For Tinnitus Market

29. Africa Digital Therapeutics For Tinnitus Market

30. Digital Therapeutics For Tinnitus Market Competitive Landscape And Company Profiles

31. Digital Therapeutics For Tinnitus Market Other Major And Innovative Companies

32. Global Digital Therapeutics For Tinnitus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Tinnitus Market

34. Recent Developments In The Digital Therapeutics For Tinnitus Market

35. Digital Therapeutics For Tinnitus Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기